Literature DB >> 17998476

Peripheral augmentation index defines the relationship between central and peripheral pulse pressure.

Shahzad Munir1, Antoine Guilcher, Tamra Kamalesh, Brian Clapp, Simon Redwood, Michael Marber, Philip Chowienczyk.   

Abstract

Peripheral systolic blood pressure is amplified above central aortic systolic pressure, but the late systolic shoulder of the peripheral pulse may approximate central systolic pressure. Because late systolic pressure also determines the peripheral augmentation index, a measure of pressure wave reflection within the systemic circulation, this implies a direct relationship between amplification and augmentation. We compared the late systolic shoulder of the peripheral pressure waveform with estimates of central systolic pressure obtained using a transfer function in 391 subjects undergoing diagnostic coronary angiography and/or elective angioplasty (30% with insignificant coronary artery disease). In a subset (n=12) we compared the late systolic shoulder of the peripheral pulse with central pressure obtained with a catheter placed in the aortic root. Measurements were made at baseline, during atrial pacing, and during administration of nitroglycerin. Late systolic shoulder pressure closely approximated transfer function estimates of central pressure (R=0.96; P<0.0001; mean difference+/-SD: 0.5+/-5.2 mm Hg). Despite changes in waveform morphology induced by pacing and nitroglycerin (reducing mean values+/-SE of the augmentation index from 76+/-3.8% to 66+/-4.6% and 60+/-3.3%, respectively), there was close agreement between the late systolic shoulder of the peripheral pulse and measured values of central pressure (R=0.96; P<0.001; mean difference: 1.7+/-4.8 mm Hg). In conclusion, the late systolic shoulder of the peripheral pulse closely approximates central systolic pressure and peripheral augmentation index, the ratio of central:peripheral pulse pressure. Interventions to lower augmentation index and peripheral vascular resistance will have multiplicative effects in lowering central blood pressure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17998476     DOI: 10.1161/HYPERTENSIONAHA.107.096016

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  40 in total

1.  Blood pressure as a drug target: what should we be measuring?

Authors:  James M Ritter
Journal:  Br J Clin Pharmacol       Date:  2012-08       Impact factor: 4.335

2.  Validity of predicting left ventricular end systolic pressure changes following an acute bout of exercise.

Authors:  Rebecca M Kappus; Sushant M Ranadive; Huimin Yan; Abbi D Lane; Marc D Cook; Grenita Hall; I Shevon Harvey; Kenneth R Wilund; Jeffrey A Woods; Bo Fernhall
Journal:  J Sci Med Sport       Date:  2012-06-20       Impact factor: 4.319

3.  Acute Heart Failure Treatment.

Authors:  Phillip D Levy; Abdel Bellou
Journal:  Curr Emerg Hosp Med Rep       Date:  2013-06-01

4.  Vasodilators in Acute Heart Failure: Review of the Latest Studies.

Authors:  Phillip D Levy; Said Laribi; Alexandre Mebazaa
Journal:  Curr Emerg Hosp Med Rep       Date:  2014-06

5.  Second derivative of the finger photoplethysmogram and cardiovascular mortality in middle-aged and elderly Japanese women.

Authors:  Noriko Inoue; Hideshi Kawakami; Hideya Yamamoto; Chikako Ito; Saeko Fujiwara; Hideo Sasaki; Yasuki Kihara
Journal:  Hypertens Res       Date:  2016-09-29       Impact factor: 3.872

6.  Comparison of telemetry and high-definition oscillometry for blood pressure measurements in conscious dogs: effects of torcetrapib.

Authors:  Olivier Meyer; Roland Jenni; Andrea Greiter-Wilke; Alexander Breidenbach; Henry H Holzgrefe
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-07       Impact factor: 1.232

7.  Noninvasive evaluation of coronary distensibility in older adults: a feasibility study with MR angiography.

Authors:  Kai Lin; Donald M Lloyd-Jones; Ying Liu; Xiaoming Bi; Debiao Li; James C Carr
Journal:  Radiology       Date:  2011-08-26       Impact factor: 11.105

8.  Differential effects of beta-adrenoreceptor antagonists on central and peripheral blood pressure at rest and during exercise.

Authors:  James A Cockburn; Sally E Brett; Antoine Guilcher; Albert Ferro; James M Ritter; Philip J Chowienczyk
Journal:  Br J Clin Pharmacol       Date:  2010-04       Impact factor: 4.335

9.  Aortic valve sclerosis is a high predictive marker of systemic endothelial dysfunction in hypertensive patients.

Authors:  T Erdoğan; M Cetin; S A Kocaman; M E Durakoğlugil; E Ergül; A Canga
Journal:  Herz       Date:  2013-02-13       Impact factor: 1.443

Review 10.  Therapeutic modification of arterial stiffness: An update and comprehensive review.

Authors:  Ching-Fen Wu; Pang-Yen Liu; Tsung-Jui Wu; Yuan Hung; Shih-Ping Yang; Gen-Min Lin
Journal:  World J Cardiol       Date:  2015-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.